Notice NOT-AG-24-091 from the NIH Guide for Grants and Contracts

Notice NOT-AI-25-019 from the NIH Guide for Grants and Contracts

Notice NOT-CA-25-031 from the NIH Guide for Grants and Contracts

Notice NOT-AG-24-033 from the NIH Guide for Grants and Contracts

Notice NOT-OD-25-061 from the NIH Guide for Grants and Contracts

Notice NOT-OD-25-054 from the NIH Guide for Grants and Contracts

Notice NOT-OD-25-062 from the NIH Guide for Grants and Contracts

Notice NOT-OD-25-060 from the NIH Guide for Grants and Contracts

Notice NOT-CA-25-028 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-25-090 from the NIH Guide for Grants and Contracts. NIDDK supports investigator-initiated, high-risk multi-center (more than one center) clinical studies through a two-part process that may include an implementation planning cooperative agreement (U34). The U34 is designed to: 1) Permit early peer review of the rationale for the proposed clinical study; 2) Permit assessment of the design and protocol of the proposed study; 3) Provide support for the development of documents needed for the conduct of the study, including a manual of operations; and 4) Support the development of other essential elements required for the conduct of the clinical study. The proposed clinical study should be hypothesis-driven and focus on a disease in the mission of NIDDK. Consultation with NIDDK scientific staff is strongly encouraged prior to the submission of the U34 application.

Funding Opportunity PAR-25-312 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) establishes an accelerated review/award process to support time-sensitive research to evaluate a new policy or program that is likely to influence obesity related behaviors (e.g., dietary intake, physical activity, or sedentary behavior) and/or weight outcomes in an effort to prevent or reduce obesity. This NOFO is intended to support research where opportunities for empirical study are, by their very nature, only available through expedited review and funding. All applications to this NOFO must demonstrate that the evaluation of an obesity related policy and /or program offers an uncommon and scientifically compelling research opportunity that will only be available if the research is initiated with minimum delay. For these reasons, applications in response to this time-sensitive NOFO are not eligible for re-submission. It is intended that eligible applications selected for funding will be awarded within 4 months of the application due date. However, administrative requirements and other unforeseen circumstances may delay issuance dates beyond that timeline.

Funding Opportunity RFA-HS-25-001 from the NIH Guide for Grants and Contracts. The purpose of this is NOFO is to disseminate patient-centered outcomes (PCOR) evidence for Long COVID care into clinical practice through clinical decision support (CDS) that is consistently updated as best practices and new evidence emerge.

Competitive: Hull University Teaching Hospitals NHS Trust: Detailed job description and main responsibilities For further details with regard to this vacancy opportunity, please see the attached Job Descript Cottingham, United Kingdom

GBP 48,235.00 - 57,255.00 per year: University of Oxford: The Kennedy Institute at the University of Oxford has an exciting opening for an experienced bioinformatician to join the group of Associate Professor Oxford, United Kingdom

Competitive: Kemio Consulting: 08th January, 2025 Senior Bioinformatician Cambridge - 3 days onsite Are you experienced working with Microbial genomic data? Are you able to ide Cambridgeshire, United Kingdom

GBP 38,232.00 - 39,866.00 per year: King's College London: About Us The post will be based in the Department of Medical and Molecular Genetics and the St John's Institute of Dermatology at King's College Lon London, United Kingdom

GBP 38,674.00 - 46,913.00 per year: University of Oxford: We have an opportunity for a Bioinformatician to work closely with the Centre for Genomic Pathogen Surveillance team of software engineers and data an Oxford, United Kingdom

Funding Opportunity PAR-25-068 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications for innovative basic and translational pilot research projects within the mission of the NIDDK that are aligned with NIH HIV/AIDS research priorities. These priorities were most recently outlined by the NIH Office of AIDS Research (OAR) in NOT-20-018, UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding, scientific priorities. Potential topics could address multiple overarching priorities. These include elucidation of unique pathophysiological mechanisms contributing to HIV comorbidities, coinfections, and complications (CCCs) affecting organs, tissues, and processes within the mission of the NIDDK. Likewise, interrogations into biological mechanisms underlying HIV reservoirs in NIDDK-relevant tissues are important for developing strategies for long-term viral suppression or eradication. Finally, health-impeding social determinants of health may affect CCCs or viral reservoirs within NIDDK's mission through multiple pathways.

Funding Opportunity PAR-25-097 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to provide support for new investigators from diverse backgrounds, including from groups nationally underrepresented in biomedical research, to conduct small research projects in the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and participating Institutes and Centers. New investigators at the time of award under this NOFO will have/have had less than $125,000 direct costs of combined research funding (excluding NIH training and NIH career awards). This R21 will support small research projects that can be carried out in a short period of time with limited resources and seeks to facilitate transition to research independence. The R21 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.

Funding Opportunity PA-25-150 from the NIH Guide for Grants and Contracts. The Joint NINDS/NIMH Exploratory Neuroscience Research Grant program supports exploratory and innovative research projects, which fall within the missions of the NINDS and NIMH. Awards will provide support for the early and conceptual stages of projects. These studies often assess the feasibility of a novel avenue of investigation and involve considerable risk, but have the potential to bring about breakthroughs in the understanding of important areas of neuroscience, or to the development of novel techniques, agents, methodologies, or models, of high value to the neuroscience community. While this funding opportunity also accepts clinical trials, only applications proposing mechanistic clinical trials or studies or basic experimental studies with humans (BESH) will be considered for funding. For information on the types of clinical trial that are within scope of this funding opportunity announcement, refer to Funding Opportunity Description, below.